Olanzapine FDA Link

A benzodiazepine derivative that binds SEROTONIN RECEPTORS; MUSCARINIC RECEPTORS; HISTAMINE H1 RECEPTORS; ADRENERGIC ALPHA-1 RECEPTORS; and DOPAMINE RECEPTORS. It is an antipsychotic agent used in the treatment of SCHIZOPHRENIA; BIPOLAR DISORDER; and MAJOR DEPRESSIVE DISORDER; it may also reduce nausea and vomiting in patients undergoing chemotherapy.

Also Known As:

Zyprexa; 2- Methyl- 4- (4- methyl- 1- piperazinyl)- 10H- thieno(2,3- b)(1,5)benzodiazepine; LY 170053; LY-170052; Olanzapine Pamoate; Zolafren; LY 170052; LY170052

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzazepines: 5
      - Benzodiazepines: 8452
        Olanzapine: 5240

Lisa Scholar Selected Research

Lisa Scholar Research Topics

Disease

Drug/Important Bio-Agent (IBA)